Proteomics Clinical Applications

Papers
(The TQCC of Proteomics Clinical Applications is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Value of Urine Peptides in Assessing Kidney and Cardiovascular Disease29
Salivary Microbiome Shifts in Response to Periodontal Treatment Outcome23
Peptides in Plasma, Urine, and Dialysate: Toward Unravelling Renal Peptide Handling21
Clinical applications of plasma proteomics and peptidomics: Towards precision medicine20
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis18
SWATH‐Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G‐CSFR Signaling16
Plasma biomarkers for systemic inflammation in COVID‐19 survivors14
Proteomic and Transcriptomic Approaches for Studying Bone Regeneration in Health and Systemically Compromised Conditions14
Deep Proteomic Insights into the Individual Short‐Term Pellicle Formation on Enamel—An In Situ Pilot Study13
Clinical Application of Mass Spectrometry‐Based Proteomics in Lung Cancer Early Diagnosis13
Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients11
Proteome Analyses Reveal S100A11, S100P, and RBM25 Are Tumor Biomarkers in Colorectal Cancer11
Proteomic profiling of human bone from different anatomical sites – A pilot study10
Deep Proteomic Insights into the Individual Short‐Term Pellicle Formation on Enamel—An In Situ Pilot Study9
Classification of Inflammatory Bowel Disease from Formalin‐Fixed, Paraffin‐Embedded Tissue Biopsies via Imaging Mass Spectrometry8
MALDI‐IMS as a Tool to Determine the Myocardial Response to Syndecan‐2‐Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy8
Is the proteomic composition of the salivary pellicle dependent on the substrate material?8
Proteomic Analysis Reveals that EPHX1 Contributes to 5‐Fluorouracil Resistance in a Human Hepatocellular Carcinoma Cell Line8
Pancreatic Tissue Proteomics Unveils Key Proteins, Pathways, and Networks Associated with Type 1 Diabetes8
Rapid Proteomic Profiling by MALDI‐TOF Mass Spectrometry for Better Brain Tumor Classification8
Comparing endocervical mucus proteome of humans and rhesus macaques7
Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis7
Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post‐DRE Urines for Quantitation and Genotype Determination7
Robust subtyping of non‐small cell lung cancer whole sections through MALDI mass spectrometry imaging7
Quantitative proteomics approach reveals novel biomarkers and pathological mechanism of keloid7
Plasma proteomics identify potential severity biomarkers from COVID‐19 associated network7
N‐Glycan profiling of chondrocytes and fibroblast‐like synoviocytes: Towards functional glycomics in osteoarthritis7
Global Proteomic Analyses of STING‐Positive and ‐Negative Macrophages Reveal STING and Non‐STING Differentially Regulated Cellular and Molecular Pathways7
A protein microarray‐based serum proteomic investigation reveals distinct autoantibody signature in colorectal cancer6
MALDI mass spectrometry imaging unravels organ and amyloid‐type specific peptide signatures in pulmonary and gastrointestinal amyloidosis6
Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS‐CoV‐2: Possible molecular mechanisms6
Dysbiosis of the Oral Ecosystem in Severe Congenital Neutropenia Patients6
Current advances in antibody‐based serum biomarker studies: From protein microarray to phage display6
Proteomics of ZIKV infected amniotic fluids of microcephalic fetuses reveals extracellular matrix and immune system dysregulation5
Revealing the changes of IgG subclass‐specific N‐glycosylation in colorectal cancer progression by high‐throughput assay5
Research progress in protein microarrays: Focussing on cancer research5
Alpha‐Synuclein Dopaminylation Presented in Plasma of Both Healthy Subjects and Parkinson's Disease Patients5
Proteomic Study Reveals the Involvement of Energy Metabolism in the Fast Antidepressant Effect of (2R, 6R)‐Hydroxy Norketamine5
Proteomic profiles of Zika virus‐infected placentas bearing fetuses with microcephaly5
Proteomic analysis identified potential age‐associated prognostic biomarkers in pneumonia‐derived paediatric sepsis5
Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease5
Integrating SWATH‐MS proteomics and transcriptome analysis to preliminarily identify three DEGs as biomarkers for proliferative diabetic retinopathy5
Plasma proteomics analysis of adolescent idiopathic scoliosis patients revealed by Quadrupole‐Orbitrap mass spectrometry5
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA4
Optimization of a lysis method to isolate periplasmic proteins from Gram‐negative bacteria for clinical mass spectrometry4
Salivary Fingerprinting of Periodontal Disease by Infrared‐ATR Spectroscopy4
Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays4
Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells4
Registration of Image Modalities for Analyses of Tissue Samples Using 3D Image Modelling4
Screening of differentially expressed proteins in placentas from patients with late‐onset preeclampsia4
Cardiomyocyte Proteome Remodeling due to Isoproterenol‐Induced Cardiac Hypertrophy during the Compensated Phase4
iTRAQ and two‐dimensional‐LC‐MS/MS reveal NAA10 is a potential biomarker in esophageal squamous cell carcinoma4
Placental and plasma early predictive biomarkers for gestational diabetes mellitus3
HIV and Proteomics: What We Have Learned from High Throughput Studies3
Development of a protein microarray for profiling circulating autoantibodies in human diseases3
Tandem mass tag‐based quantitative proteomic analysis of cervical cancer3
Plasma proteome profiling using tandem mass tag labeling technology reveals potential biomarkers for Parkinson's disease: a preliminary study3
Quantitative proteomics analysis identifies salivary biomarkers for early detection of pregnancy loss in a Singaporean cohort—A pilot study3
Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non‐responders' tumor tissue3
Primary angle closure glaucoma is characterized by altered extracellular matrix homeostasis in the iris3
Label‐free quantitative proteomics identifies unique proteomes of clinical isolates of the Liverpool Epidemic Strain of Pseudomonas aeruginosa and laboratory strain PAO13
Revisiting “‐omics” in Oral Health and Disease3
Proteoglycans in breast cancer, identification and characterization by LC‐MS/MS assisted proteomics approach: A review3
Proteomic study of apheresis platelets made HLA class I deficient for transfusion of refractory patients3
Mass spectrometry‐based proteomic analysis of the effect of storage temperature on non‐invasively collected samples of human stratum corneum3
A proteomic investigation of isogenic radiation resistant prostate cancer cell lines3
Differential Protein Expression between Cystic and Solid Vestibular Schwannoma Using Tandem Mass Tag‐Based Quantitative Proteomic Analysis3
Evaluation of the Aortopathy in the Ascending Aorta: The Novelty of Using Matrix‐Assisted Laser Desorption/Ionization Imaging3
Protein profiles in plasma: Development from infancy to 5 years of age3
0.045077085494995